Holmlin provided updated full-year 2025 revenue guidance, stating "we expect full year revenues to be in the range of $26 million to $30 million which is an update compared to our previous views on ...
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 represents the first ...
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of ...
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results